Term
|
Definition
1) amnesia - occurs through depressing neuronal activity 2) immobility in response to noxious stimuliation - inhibiting concious brain activity or nerve reflexes; 3) attenuation of autonomic response to noxious stimuli |
|
|
Term
|
Definition
use of multiple drugs to achieve desired depth of aneshtesia |
|
|
Term
|
Definition
barbiturates, diazepam, midazolam, atropine (blocks ACh effect on heart), 5-HT3 receptor antagonist (ondansetron - prevent vomiting), H-2 antagonist (ranitidine - acid reflux) |
|
|
Term
Intravenous GAs - sodiuim thiopental [Pentothal], propofol [Diprivan], etomidate [Amidate], ketamine [Ketalar] |
|
Definition
used to induce anesthesia - faster acting |
|
|
Term
Inhaled GAs - nitrous oxide [N2O], halothane [Fluothane], isoflurane [Forane], enflurane [Ethrane], desflurane [Suprane], sevoflurane [Ultane] |
|
Definition
used to maintain anesthesia; have unpleasant odor and may irritate air passageways; can constantly be monitored |
|
|
Term
|
Definition
neuromuscular junction blocker used as needed for GA; mainly for endotracheal intubation |
|
|
Term
fentanyl, other analgesics |
|
Definition
used to reduce dose of GAs and specifically block noxious stimulus reflex in autonomic nervous system |
|
|
Term
|
Definition
condition where half-concious pts exhibit restlessness, crying, moaning, and thrashing; pts often have HTN and tachycardia as a result of rebound effect from effects of GAs wearing off |
|
|
Term
|
Definition
drug given to reduce shivering threshold when coming out of general anesthesia |
|
|
Term
|
Definition
avoid these drugs until effects of GAs have worn off |
|
|
Term
|
Definition
MOST important factor affecting inhaled GAs |
|
|
Term
high water solubility = slow induction |
|
Definition
it takes a long for inhaled GA to first dissolve in blood before entering CNS |
|
|
Term
low water solubility = rapid induction |
|
Definition
inhaled GA is NOT soluble in blood & rapidly goes from blood to CNS |
|
|
Term
|
Definition
poorly soluble in blood (partition coefficient = 0.47) AND low lipid solubility --> rapid induction, fast acting, AND not very potent; MAC = 105%; by itself it cannot achieve desired depth of anesthesia; colorless, odorless gas --> used to induce analgesia in dentist office; SEs: middle ear air pockets may expand; depresses ventillary response to hypoxia; does NOT trigger malignant hyperthermia |
|
|
Term
|
Definition
inaled GA; MAC = 0.75%; MOST POTENT; no pungent odor; very soluble in blood (partition coefficient = 2.3)--> slowest induction --> slowest recovery; SEs: 20-25% decrease in BP; vasodilation; decreased CO, bradycardia; decrease renal blood flow; muscle relaxation; decrease ventilation rate; hepatitis |
|
|
Term
Minimum Alveolar Concentration (MAC) |
|
Definition
meausres potency; the concentration of inhaled GA needed for 50% of pts to NOT respond to pain |
|
|
Term
|
Definition
|
|
Term
MAC is proportional to Lipid Solubility |
|
Definition
high lipid solubility --> greater potency (MAC); low lipid solubility --> lower potency (MAC) |
|
|
Term
|
Definition
inhaled GA still used in 3rd world countries; cheap & effective; SEs: irritates airways, flammable High water AND high lipid solubility = slow-acting AND very potent |
|
|
Term
MAC for Maintenance of Anesthesia |
|
Definition
|
|
Term
|
Definition
inhaled GA; major anesthetic in US from 30's to 60's; SEs: "spontaneous combustion" on operating table; highly flammable |
|
|
Term
|
Definition
inhaled GA MAC = 1.6%; sweet odor; Partition coeffecient = 1.8 --> slower induction; SEs: decrease BP, decreased cardiomyocyte contractility, peripheral vasodilation; electrical seizure activity (C/I for epilepsy); muscle relaxation (enhanced with NMJ blockers); decrease in ventilation rate |
|
|
Term
|
Definition
inhaled GA MAC = 1.2%; pungent odor; Partition Coefficient = 1.4 --> medium induction; >99% eliminated unchanged via lungs; SEs: decrease in BP, vasodilation, mild tachycardia, decreased renal blood flow, muscle relaxation (enhanced with NJM blocker) Preferred GA for neurosurgery; |
|
|
Term
|
Definition
inhaled GA MAC = 6%; irritating gas --> coughing, respiratory secretions, MUST USE IV GA to induce anesthesia; Partition coefficient = 0.45 --> rapid induction; SEs: decreased BP, ventilation rate; tachycardia |
|
|
Term
|
Definition
inhaled GA MAC = 2%; reacts with dried out soda lime to produce CO; Partition coefficient = 0.65; SEs: decreased BP, systemic vasodilation; Preferred GA for pts prone to myocardial ischemia; Short term renal damage (Compound A formation) |
|
|
Term
sodium thiopental [Pentothal] |
|
Definition
IV GA; Induction dose: 3-5 mg/kg; Induction time = 1 min Duration of action = 5-8 min;; Initial drug used in current lethal injection protocol; LD50 = 50 mg/kg; pH = 10-11 --> drug precipitation if mixed with acidic drugs; MoA: barbiturate; SEs: decrease brains metabolic rate, decreases BP, vasodilation, decreases heart contractility, decreases ventilation rate; "hangover" effect if injected multiple times |
|
|
Term
|
Definition
IV GA; induction dose: 1.5-2.5 mg/kg; Duration of ACtion: 4-8 min; NOT water soluble --> VERY lipid soluble (use w/ caution in pts w/ high triglycerides); Most common induction agent; LACK of hangover effect; Allows pts to be discharged faster, good for outpatient procedures; MoA: enhances effects of GABA at GABA-A receptors; SEs: MAJOR decrease in BP, vasodilation, decraase in myocardial contractility; decrease in ventilation rate; anti-emetic properties; does NOT cross placenta (safe for pregnant women) |
|
|
Term
|
Definition
IV GA; Induction dose: 0.2-0.4 mg/kg Duration of action: 4-8 min NOT water soluble; Used for pts at risk for hypotension; Used for induction & maintenance of anesthesia; SEs: myoclonic movements (tx w/ benzodiazepines); nausea, vomiting; |
|
|
Term
|
Definition
IV GA; Induction dose: 0.5-1.5 mg/kg; Duration of Action: 10-15 min WATER SOLUBLE; produces PROFOUND analgesia; used in military, battlefield; MoA: NMDA competetive antagonist, inhibition of Na, K channels; SEs: increased cerebral blood flow, EMERGENCE DELIRIUM (1 hr post emergence), hallucinations, vivid dreams, illusions; modest decrease in ventilation, potent bronchodilator; incrrease BP, CO, HR --> risky for pts with hypotension |
|
|
Term
benzodiazepines - midazolam >>> diazepam > lorazepam |
|
Definition
can produce anesthesia but at doses that would result in prolonged amnesia & sedation; Give IV, oral, rectal, or IM; Uses: Pre-op sedation; |
|
|
Term
|
Definition
water soluble benzodiazepine; no pain on injection site; more rapid onset (2 min IV), rapid recovery |
|
|
Term
opioids - fentanyl (100x more potent than morphine) |
|
Definition
potent analgesics; Given at induction for later intubation, initial incision; Minimizes vascular reflex to noxious, painful stimuli; SEs: nausea, vomiting; decreased ventilation rate, decreased HR, decrease in BP |
|
|
Term
|
Definition
100x more potent than morphine; used in Russian hostage/terrorist actions; duration of action: 30 min; |
|
|
Term
|
Definition
shortest duration of action (10 min) of opioids |
|
|
Term
alpha-2 adrenergic agonist - dexmedetomidine |
|
Definition
approved for sedation in critically ill pts; off label use as GA adjunct; IV use only; useful in non-intubated pts |
|
|
Term
alpha-2 adrenergic agonist - dexmedetomidine |
|
Definition
approved for sedation in critically ill pts; off label use as GA adjunct; IV use only; useful in non-intubated pts |
|
|
Term
|
Definition
core body temp < 36 degrees C; due to exposed body cavities, IV fluid at room temp, vasodilation of skin, normal room temp is 21 or colder; Warming efforts: heated surgical beds, heat air that is inhaled with GA, water-filled garments with microprocessor control of body temp. |
|
|
Term
|
Definition
core body temp reaches 42 degrees C with muscle rigidity; can occur in most GAs and some NJM blockers; Mechanism: ryanodine Ca channels do NOT close --> uncontrolled muscle contraction leading to heat generation --> myocytes lyse releasing K causing fatal cardiac effects; Tx: dantrolene (Dantrium) - ryanodine receptor inhibitor, also used to tx muscle spasms |
|
|
Term
|
Definition
ryanodine receptor inhibitor; also used to treat spasms; used to treat malignant hyperthermia due to GAs |
|
|